ArticlePloS one2017

Intervention using a novel biodegradable hollow stent containing polylactic acid-polyprolactone-polyethylene glycol complexes against lacrimal duct obstruction disease.

Xinyuan Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.